199 related articles for article (PubMed ID: 6228035)
1. Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC.
Brewer JA; Hank JA; Wendel T; Schmeling GJ; Blank JL; Morrissey LW; Robins HI; Sondel PM
Tissue Antigens; 1983 Oct; 22(4):246-56. PubMed ID: 6228035
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment.
Gruner S; Volk HD; Noack F; Meffert H; von Baehr R
Tissue Antigens; 1986 Mar; 27(3):147-54. PubMed ID: 2940731
[TBL] [Abstract][Full Text] [Related]
3. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D.
Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E
Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440
[TBL] [Abstract][Full Text] [Related]
4. Functional defect of heat-inactivated human lymphocytes in mixed-lymphocyte culture.
Boyer CM; Kostyu DD; Brissette CS; Amos DB
Cell Immunol; 1986 Sep; 101(2):440-53. PubMed ID: 2944610
[TBL] [Abstract][Full Text] [Related]
5. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
[TBL] [Abstract][Full Text] [Related]
6. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens.
Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ
Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
9. An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.
Taylor GM; Fergusson W; Dyer PA; Harris R; Morrell G
Cancer Immunol Immunother; 1983; 16(2):117-22. PubMed ID: 6229327
[TBL] [Abstract][Full Text] [Related]
10. The active rosette mixed-lymphocyte reaction: an early marker of lymphocyte activation linked to HLA-D-DR differences.
Wybran J; Dupont E
Clin Immunol Immunopathol; 1983 Apr; 27(1):51-5. PubMed ID: 6223752
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel.
Persitz E; Oksenberg J; Amar A; Margalioth EJ; Cohen O; Brautbar C
Gynecol Obstet Invest; 1983; 16(5):283-91. PubMed ID: 6227533
[TBL] [Abstract][Full Text] [Related]
12. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.
Shaut DM; Ireland J; Scornik JC; Peck AB
Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790
[TBL] [Abstract][Full Text] [Related]
13. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
14. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.
Taramelli D; Fossati G; Balsari A; Marolda R; Parmiani G
Int J Cancer; 1984 Dec; 34(6):797-806. PubMed ID: 6334655
[TBL] [Abstract][Full Text] [Related]
16. Plaque-forming cells in man. III. Generation of plaque-forming cells in allogeneic in vitro cultures of HLA-D/DR-incompatible B and T lymphocytes.
Tauris P; Johnsen HE; Christiansen SE; Kissmeyer-Nielsen F
Scand J Immunol; 1984 May; 19(5):419-24. PubMed ID: 6233695
[TBL] [Abstract][Full Text] [Related]
17. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen.
Goeken NE
J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315
[TBL] [Abstract][Full Text] [Related]
18. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
Breuning MH; Breur BS; Engelsma MY; Iványi P
Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
[TBL] [Abstract][Full Text] [Related]
19. Loss of HLA-DR expression by human epidermal cells after growth in culture.
Hefton JM; Amberson JB; Biozes DG; Weksler ME
J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639
[TBL] [Abstract][Full Text] [Related]
20. Serological distinction between DR antigens and lymphocyte activating determinants.
van Heyningen V; Cohen BB; Deane DL; Gray C; Steel CM
Tissue Antigens; 1981 Feb; 17(2):149-61. PubMed ID: 6165093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
